Health
Medical
Consulting
Mednax
$28.859876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$28.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.08 (-0.28%) Today
-$0.08 (-0.28%) Today
Why Robinhood?
You can buy or sell Mednax and other stocks, options, ETFs, and crypto commission-free!
About
MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company's solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting. Read More MEDNAX was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.
Employees
16,085
Headquarters
Sunrise, Florida
Founded
1979
Market Cap
2.54B
Price-Earnings Ratio
9.86
Dividend Yield
0.00
Average Volume
918.96K
High Today
$29.03
Low Today
$28.75
Open Price
$28.85
Volume
8.97K
52 Week High
$56.46
52 Week Low
$28.75
Collections
Health
Medical
Consulting
Business Services
US
North America
News
Guru FocusMar 22
Stocks That Fell to 3-Year Lows in the Week of March 22
UBS Group AG (NYSE:UBS), AutoNation Inc. (NYSE:AN), Mednax Inc. (NYSE:MD) and Amdocs Ltd. (NASDAQ:DOX) have declined to three-year lows. UBS Group declined to $11.88 The price of UBS Group shares declined to $11.88 on March 22, which is only 2.3% above the three-year low of $11.61. UBS is a Swiss investment bank and financial services company. It is known for its strict bank-client confidentiality and culture of banking secrecy. The company has a market cap of $46.05 billion; its shares were traded arou...
Simply Wall StMar 21
Are Insiders Selling MEDNAX, Inc. (NYSE:MD) Stock?
We’ve lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On the other hand, we’d be remiss not to mention that insider sales have been known to precede tough periods for a business. So shareholders might well want to know whether insiders have been buying or selling shares in MEDNAX, Inc. (NYSE:MD). Do Insider Transactions Matter? It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most ...
TradingNewsNowMar 13
Buy or Sell: Mednax (NYSE: MD)
Mednax trades as part of the health care providers industry and healthcare sector. The company CEO is Roger J. Medel. Mednax Inc is a provider of physician services that are newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. Anesthesiology and Neonatology and other pediatric subspecialties generate more income. Previous Intraday Trading Performance: The MD stock showed a previous change of 0.77% with an open at 29.96 and a close of 30.03. It rea...
Price Paid on Robinhood
27% Lower
Right Now
52 Week Low
$28.88
Average Price Paid
$39.65
52 Week High
$56.46
Earnings
$0.84
$0.92
$0.99
$1.07
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected Apr 29, Pre-Market